|
31 |
Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
Valor-Méndez, Larissa. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2022
|
|
|
32 |
GLODAPv2.2022: the latest version of the global interior ocean biogeochemical data product
Enthalten in Earth system science data Bd. 14, 2022, Nr. 12: 5543-5572. 30 S.
|
|
|
|
33 |
Effectiveness of SB4 transition from originator etanercept in rheumatoid arthritis and axial spondyloarthritis: A subgroup analysis from the BENEFIT study
Enthalten in Rheumatology and immunology research Bd. 3, 2022, Nr. 1: 31-37. 7 S.
|
|
|
|
34 |
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial
Rugo, Hope S.. - Freiburg : Universität, 2021
|
|
|
|
35 |
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer
Rugo, Hope S.. - Freiburg : Universität, 2021
|
|
|
|
36 |
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Fischer, Sarah Cornelia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2021
|
|
|
|
37 |
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Fischer, Sarah Cornelia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2021
|
|
|
38 |
[Handke]
Vtoroj meč
Handke, Peter. - Moskva : Inspiria, 2021, Literaturno-chudožestvennoe izdanie
|
|
|
|
39 |
Biosimilars in der Kinderrheumatologie
Enthalten in Kinder- und Jugendmedizin Bd. 21, 2021, Nr. 05: 339-348
|
|
|
|
40 |
Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
Enthalten in BioDrugs 6.12.2021: 1-13
|
|
Administration
